Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation

scientific article published on 13 October 2013

Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1035068060
P356DOI10.1038/NCHEMBIO.1361
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/nchembio.1361
P932PMC publication ID3970981
P698PubMed publication ID24121552
P5875ResearchGate publication ID257754445

P2093author name stringEric D Brown
Lauren F Ferruccio
Soumaya Zlitni
P2860cites workConstruction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collectionQ22122301
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of AmericaQ24601746
Biotin synthesis begins by hijacking the fatty acid synthetic pathwayQ24629071
Fiji: an open-source platform for biological-image analysisQ27860912
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysQ28145712
5-Fluorouracil: mechanisms of action and clinical strategiesQ28201937
Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotesQ28238338
Target identification in chemical genetics: the (often) missing linkQ28262958
Metabolism and action of amino acid analog anti-cancer agentsQ28298599
Biosynthesis of 7, 8-diaminopelargonic acid from 7-keto-8-aminopelargonic acid and S-adenosyl-L-methionine. The kinetics of the reactionQ28336637
Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionQ28477282
Drugs for bad bugs: confronting the challenges of antibacterial discoveryQ29547723
Nucleotide biosynthesis is critical for growth of bacteria in human bloodQ30841127
Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathwaysQ30885679
Existence of two D-alanine:D-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the DdlA and DdlB enzymesQ30909765
Comprehensive essential gene identification as a platform for novel anti-infective drug discovery.Q31070591
Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibilityQ31121406
Large-scale identification of virulence genes from Streptococcus pneumoniae.Q31968558
A comprehensive library of fluorescent transcriptional reporters for Escherichia coliQ33251466
An integrated platform of genomic assays reveals small-molecule bioactivitiesQ33351287
Functional genomics: expression analysis of Escherichia coli growing on minimal and rich mediaQ33638195
Considerations when prescribing trimethoprim-sulfamethoxazoleQ34223201
Structural enzymology of biotin biosynthesisQ34232138
Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novoQ34241048
The effect of amino acid analogues on growth and protein synthesis in microorganismsQ35544195
Chemogenomic profiling: identifying the functional interactions of small molecules in yeastQ35554300
Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesisQ35689501
Metabolism of 6-aminonicotinic acid in Escherichia coliQ36603676
Mechanism of d -Cycloserine Action: Transport Systems for d -Alanine, d -Cycloserine, l -Alanine, and GlycineQ36787670
Speculative strategies for new antibacterials: all roads should not lead to RomeQ38101243
Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants.Q39569905
The behavior and significance of slow-binding enzyme inhibitorsQ39635194
Sulfonamides and folic acid antagonists: a historical reviewQ39663235
Comparative action of glyphosate as a trigger of energy drain in eubacteriaQ39961774
Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat culturesQ40743914
Chorismate aminations: partial purification of Escherichia coli PABA synthase and mechanistic comparison with anthranilate synthaseQ42212750
Is the GAIN Act a turning point in new antibiotic discovery?Q42268705
Utilization of L-threnonine by a pseudomonad: a catabolic role for L-threonine aldolaseQ42934746
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.Q43270534
The construction of systematic in-frame, single-gene knockout mutant collection in Escherichia coli K-12.Q54424353
Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenicQ57805088
Slow-binding inhibition of gamma-aminobutyric acid aminotransferase by hydrazine analoguesQ70939325
Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesisQ73909083
THE ENZYMATIC SYNTHESIS OF D-ALANYL-D-ALANINE. 3. ON THE INHIBITION OF D-ALANYL-D-ALANINE SYNTHETASE BY THE ANTIBIOTIC D-CYCLOSERINEQ76900696
Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphateQ78868845
An agar plate assay for biotinQ82351577
Metabolism of 6-aminonicotinic acid in Escherichia coli.Q105009312
P433issue12
P304page(s)796-804
P577publication date2013-10-13
P1433published inNature Chemical BiologyQ904026
P1476titleMetabolic suppression identifies new antibacterial inhibitors under nutrient limitation
P478volume9

Reverse relations

cites work (P2860)
Q482412498-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Q89965407A Moraxella Virulence Factor Catalyzes an Essential Esterase Reaction of Biotin Biosynthesis
Q96230670A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii
Q38990080A robust platform for chemical genomics in bacterial systems.
Q47804224Actinorhodin is a redox-active antibiotic with a complex mode of action against Gram-positive cells.
Q36055552Antagonism screen for inhibitors of bacterial cell wall biogenesis uncovers an inhibitor of undecaprenyl diphosphate synthase
Q38704810Antibacterial drug discovery in the resistance era.
Q40163906Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy-d-xylulose 5-Phosphate Synthase.
Q93074400Chemical-Chemical Combinations Map Uncharted Interactions in Escherichia coli under Nutrient Stress
Q36277847Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis
Q62673364Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Q46899589Drug discovery: Leaving no stone unturned
Q91650255Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance
Q30636019Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum
Q33708635Expression and Activity of the BioH Esterase of Biotin Synthesis is Independent of Genome Context
Q35661873Fragment-based exploration of binding site flexibility in Mycobacterium tuberculosis BioA.
Q55093817Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.
Q58569022High-Throughput Screening of Biodiversity for Antibiotic Discovery
Q53707434High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds.
Q33653817Horizontally Acquired Biosynthesis Genes Boost Coxiella burnetii's Physiology
Q27681548Inhibition ofMycobacterium tuberculosisTransaminase BioA by Aryl Hydrazines and Hydrazides
Q49914281Integrated Metabolomics and Morphogenesis Reveals Volatile Signaling of the Nematode-Trapping Fungus Arthrobotrys oligospora.
Q48175708Mechanistic Basis for ATP-Dependent Inhibition of Glutamine Synthetase by Tabtoxinine-β-lactam
Q99550899Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections
Q90317498Metabolic dependency of chorismate in Plasmodium falciparum suggests an alternative source for the ubiquinone biosynthesis precursor
Q90975671Mimicking the human environment in mice reveals that inhibiting biotin biosynthesis is effective against antibiotic-resistant pathogens
Q54259390Mutual potentiation drives synergy between trimethoprim and sulfamethoxazole.
Q26799749Next-generation antimicrobials: from chemical biology to first-in-class drugs
Q58549114Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli
Q40189627Opportunities for natural products in 21st century antibiotic discovery
Q41365032Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents
Q91866694Revitalizing antifolates through understanding mechanisms that govern susceptibility and resistance
Q27702218Selective small-molecule inhibition of an RNA structural element
Q38710256Strategies for target identification of antimicrobial natural products
Q30393244Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis
Q37460655Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates
Q39159676The Genome-Wide Interaction Network of Nutrient Stress Genes in Escherichia coli
Q90675577The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in Staphylococcus aureus Dihydropteroate Synthase
Q38534653Unconventional screening approaches for antibiotic discovery
Q36730046Untargeted Metabolomics To Ascertain Antibiotic Modes of Action.
Q55456503Vitamin Biosynthesis as an Antifungal Target.

Search more.